Microbix Biosystems Financials

MBX Stock  CAD 0.31  0.01  3.33%   
We recommend to make use of Microbix Biosystems fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of Microbix Biosystems as well as the relationship between them. We have analyzed and interpolated thirty-one available fundamentals for Microbix Biosystems, which can be compared to its peers in the industry. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of Microbix Biosystems to be traded at C$0.372 in 90 days. Key indicators impacting Microbix Biosystems' financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.20.21
Sufficiently Down
Slightly volatile
Current Ratio2.975.9
Way Down
Slightly volatile
  
Understanding current and past Microbix Biosystems Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Microbix Biosystems' financial statements are interrelated, with each one affecting the others. For example, an increase in Microbix Biosystems' assets may result in an increase in income on the income statement.

Microbix Biosystems Stock Summary

Microbix Biosystems Inc., a life science company, manufactures viral and bacterial antigens and reagents for the diagnostics industry worldwide. Microbix Biosystems Inc. was founded in 1988 and is based in Mississauga, Canada. MICROBIX J is traded on Toronto Stock Exchange in Canada.
Foreign Associate
  USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentCanada Stock View All
ExchangeToronto Exchange
ISINCA59501P1045
Business Address265 Watline Avenue,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.microbix.com
Phone905 361 8910
CurrencyCAD - Canadian Dollar
You should never invest in Microbix Biosystems without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Microbix Stock, because this is throwing your money away. Analyzing the key information contained in Microbix Biosystems' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Microbix Biosystems Key Financial Ratios

Microbix Biosystems' financial ratios allow both analysts and investors to convert raw data from Microbix Biosystems' financial statements into concise, actionable information that can be used to evaluate the performance of Microbix Biosystems over time and compare it to other companies across industries.

Microbix Biosystems Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets15.6M28.8M33.1M35.7M41.0M43.1M
Other Current Liab1.5M1.8M1.8M2.0M2.3M1.3M
Net Debt6.1M(2.3M)(7.7M)(5.0M)(5.7M)(5.4M)
Retained Earnings(41.9M)(38.7M)(36.9M)(36.9M)(33.2M)(31.6M)
Accounts Payable1.5M1.8M1.8M2.1M2.4M1.5M
Cash92.7K10.0M13.5M11.6M13.3M14.0M
Net Receivables1.9M4.2M3.1M4.2M4.8M5.0M
Inventory4.3M4.4M5.3M5.8M6.6M6.9M
Other Current Assets220.1K495.0K546.3K767.5K882.6K926.7K
Total Liab9.0M10.3M8.2M11.0M12.7M6.5M
Total Current Assets6.5M19.1M22.4M22.3M25.6M26.9M
Short Term Debt1.3M2.7M267.4K265.4K305.2K290.0K
Intangible Assets1.7M1.7M1.5M4.4M5.1M3.5M
Common Stock35.4M43.6M49.9M49.0M56.4M35.8M
Net Tangible Assets5.6M4.9M16.9M23.4M27.0M28.3M
Long Term Debt4.5M4.1M4.7M5.7M5.1M3.8M
Short Long Term Debt2.6M1.1M2.4M111.1K100.0K95.0K
Long Term Debt Total4.3M4.9M5.1M5.6M6.4M5.5M
Capital Surpluse9.4M10.3M10.7M9.6M11.1M9.2M
Net Invested Capital12.3M25.1M29.8M30.4M35.0M24.1M
Net Working Capital2.4M13.9M19.8M18.0M20.6M21.7M
Capital Stock35.4M43.6M49.9M49.0M56.4M45.1M

Microbix Biosystems Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense1.1M1.6M826.6K839.4K965.3K540.3K
Total Revenue10.5M18.6M19.1M16.5M19.0M19.9M
Gross Profit4.7M11.0M11.1M7.5M8.6M4.4M
Operating Income(524.6K)4.8M2.7M(2.7M)(3.1M)(3.0M)
Ebit(3.6M)4.8M2.7M799.9K919.9K965.9K
Research Development1.0M1.0M1.8M2.0M2.4M2.5M
Ebitda(2.9M)5.7M3.7M2.0M2.3M2.4M
Cost Of Revenue5.9M7.5M8.0M9.0M10.4M10.9M
Net Income(6.2M)1.6M1.8M(39.5K)(35.5K)(37.3K)
Income Tax Expense1.6M1.6M77.2K839.4K755.4K793.2K
Income Before Tax(4.7M)3.2M1.9M(39.5K)(35.5K)(37.3K)
Net Interest Income(1.1M)(1.6M)(744.3K)(381.6K)(438.9K)(460.8K)

Microbix Biosystems Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash(2.9K)9.9M3.5M(1.9M)(2.2M)(2.1M)
Free Cash Flow(805.3K)804.2K1.4M(2.1M)(2.4M)(2.5M)
Depreciation690.1K822.0K1.0M1.2M1.3M1.4M
Other Non Cash Items3.4M892.0K330.5K(2.7M)(3.1M)(3.0M)
Capital Expenditures813.9K1.3M2.0M1.0M1.2M1.1M
Net Income(6.2M)3.2M1.8M(39.5K)(45.4K)(47.7K)
End Period Cash Flow92.7K10.0M13.5M11.6M13.3M14.0M
Change To Inventory187.5K(114.8K)(877.4K)(467.1K)(420.4K)(399.4K)
Net Borrowings521.6K(1.3M)83.8K(1.4M)(1.2M)(1.2M)
Change To Netincome372.3K5.1M1.3M980.2K1.1M1.1M
Investments(813.9K)(622.3K)(2.0M)(1.0M)(914.6K)(960.3K)

Microbix Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Microbix Biosystems's current stock value. Our valuation model uses many indicators to compare Microbix Biosystems value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Microbix Biosystems competition to find correlations between indicators driving Microbix Biosystems's intrinsic value. More Info.
Microbix Biosystems is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about  0.19  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Microbix Biosystems is roughly  5.25 . At this time, Microbix Biosystems' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Microbix Biosystems by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Microbix Biosystems' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Microbix Biosystems Systematic Risk

Microbix Biosystems' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Microbix Biosystems volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was four with a total number of output elements of fifty-seven. The Beta measures systematic risk based on how returns on Microbix Biosystems correlated with the market. If Beta is less than 0 Microbix Biosystems generally moves in the opposite direction as compared to the market. If Microbix Biosystems Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Microbix Biosystems is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Microbix Biosystems is generally in the same direction as the market. If Beta > 1 Microbix Biosystems moves generally in the same direction as, but more than the movement of the benchmark.

Microbix Biosystems Total Assets Over Time

Today, most investors in Microbix Biosystems Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Microbix Biosystems' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Microbix Biosystems growth as a starting point in their analysis.

Price Earnings To Growth Ratio

12.78

At this time, Microbix Biosystems' Price Earnings To Growth Ratio is very stable compared to the past year.

Microbix Biosystems November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Microbix Biosystems help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Microbix Biosystems. We use our internally-developed statistical techniques to arrive at the intrinsic value of Microbix Biosystems based on widely used predictive technical indicators. In general, we focus on analyzing Microbix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Microbix Biosystems's daily price indicators and compare them against related drivers.

Other Information on Investing in Microbix Stock

Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.